These Analysts Slash Their Forecasts On Paycor HCM Following Q4 Results
These Analysts Slash Their Forecasts On Paycor HCM Following Q4 Results
Paycor said it sees first-quarter revenue between $161 million to $163 million and expects FY25 revenue between $722 million to $729 million.Paycor HCM, Inc. (NASDAQ:PYCR) reported better-than-expected fourth-quarter financial results on Wednesday.
週三，Paycor HCm（納斯達克股票代碼：PYCR）報告了好於預期的第四季度財務業績。
Paycor HCM reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 9 cents per share. The company reported quarterly sales of $164.800 million which beat the analyst consensus estimate of $161.172 million.
Paycor HCm報告季度每股收益爲11美分，超過了分析師預期的9美分。該公司報告的季度銷售額爲16480萬美元，超過了分析師預期的16117.2萬美元。
"Paycor delivered revenue growth of 18% for the quarter and 19% for the year, propelled by strong execution against our strategic growth initiatives to add employees and expand PEPM," said Raul Villar, Jr., Chief Executive Officer of Paycor. "We continued winning market share by delivering substantial value through our robust, modern HCM solution that powers people and performance."
「Paycor的營業收入在本季度增長了18％，全年增長了19％，這是由於我們成功執行了戰略增長計劃，增加了員工並擴大PEPm的業務，」Paycor首席執行官Raul Villar, Jr.說，「我們通過提供強大，現代的HCm解決方案來提供巨大的價值，以增加市場份額，並提升人員和表現水平。」
Paycor said it sees first-quarter revenue between $161 million to $163 million and expects FY25 revenue between $722 million to $729 million.
Paycor表示，它預計第一季度營收爲1.61億至1.63億美元，並預計FY25營收爲7.22億至7.29億美元。
Paycor HCM shares gained 2.7% to close at $12.63 on Wednesday.
週三，Paycor HCm股票上漲2.7％，收於12.63美元。
These analysts made changes to their price targets on Paycor HCM following earnings announcement.
這些分析師在業績公佈後對Paycor HCm的目標股價進行了調整。
- Needham analyst Scott Berg maintained Paycor HCM with a Buy and lowered the price target from $42 to $20.
- BTIG analyst Matt VanVliet maintained Paycor HCM with a Buy and cut the price target from $26 to $20.
- Stifel analyst Brad Reback maintained the stock with a Buy and lowered the price target from $22 to $19.
- JP Morgan analyst Mark Murphy maintained Paycor HCM with a Neutral and lowered the price target from $19 to $17.
- Needham的分析師Scott Berg保持Paycor HCm的買入評級，並將價格目標從42美元下調至20美元。
- BTIG分析師Matt VanVliet保持Paycor HCm的買入評級，並將價格目標從26美元下調至20美元。
- Stifel分析師Brad Reback保持該股票的買入評級，並將價格目標從22美元下調至19美元。
- JP Morgan的分析師Mark Murphy維持Paycor HCm的中立評級，並將價格目標從19美元下調至17美元。
Considering buying PYCR stock? Here's what analysts think:
考慮購買PYCR股票？以下是分析師的意見：
- Pfizer, Conagra Brands And 2 Other Stocks Insiders Are Selling
- 輝瑞、康尼格拉品牌和其他兩隻股票的內部人士正在出售。
譯文內容由第三人軟體翻譯。